Business Context and Reporting Period
Muzero Acquisition Corp (MUZE) is a Cayman Islands exempted company and a Special Purpose Acquisition Company (SPAC) incorporated on October 10, 2025. The company is an emerging growth company and a shell company focused on effecting a merger, amalgamation, or similar business combination with one or more target businesses. The reporting period covers the three months ended March 31, 2026. The company consummated its Initial Public Offering (IPO) on February 2, 2026, and has not yet commenced operations or selected a specific business combination target.
Key Financial Metrics
| Metric | Value (Three Months Ended March 31, 2026) |
|---|---|
| Net Income | $921,491 |
| Operating Expenses | $205,230 |
| Interest Income (Trust Account) | $1,124,142 |
| Cash and Cash Equivalents (Outside Trust) | $934,577 |
| Investments Held in Trust Account | $202,374,142 |
| Working Capital | $952,267 |
| Deferred Underwriting Fee | $7,043,750 |
| Net Cash Provided by Financing Activities | $202,555,266 |
Material Changes vs. Prior Period
The financial position changed significantly due to the consummation of the IPO on February 2, 2026, compared to the pre-IPO period ending December 31, 2025.
- Assets: Total assets increased from $198,950 to $203,574,958, driven primarily by the placement of $201,250,000 into the Trust Account.
- Liabilities: Total liabilities increased from $223,491 to $7,209,200, primarily due to the recognition of the $7,043,750 deferred underwriting fee.
- Equity: The company moved from a shareholders' deficit of $(24,541) to $(6,008,384) due to the accretion of Class A ordinary shares to their redemption value, offset by the issuance of private placement units and net income.
- Revenue/Income: The company generated no operating revenue. Net income of $921,491 was derived almost entirely from interest earned on the Trust Account ($1,124,142) and cash equivalents ($2,579), offset by general and administrative expenses.
Outlook, Risks, and Management Commentary
Outlook and Liquidity: Management believes the company has sufficient funds to finance working capital needs for one year from the date of issuance. The company has until February 2, 2028 (24 months from IPO closing) to consummate a business combination. If unsuccessful, the company will redeem public shares and liquidate.
Risks and Contingencies:
- Delisting Risk: The company faces a risk of suspension and delisting from Nasdaq if it fails to meet the Nasdaq 36-Month Requirement for completing a business combination.
- Going Concern: While management does not currently anticipate needing additional funds, insufficient funds could arise if actual costs exceed estimates for identifying and negotiating a target.
- Trust Account: Funds in the Trust Account are subject to claims of creditors, which could have priority over public shareholders' claims.
- Related Party Transactions: The Sponsor has agreed to indemnify the company for claims reducing Trust Account funds below $10.00 per share, though the company has not verified the Sponsor's ability to satisfy this obligation.
Unusual Items: The financial statements reflect significant non-cash adjustments, including the accretion of Class A shares to redemption value ($14,524,110) and the fair value allocation of public warrants ($2,918,125).
Investor Verification Checklist
- Trust Account Balance: Verify the current balance of $202,374,142 and the accrued interest component ($610,505) to ensure accurate per-share redemption value.
- Deferred Fee Obligation: Confirm the $7,043,750 deferred underwriting fee payable upon business combination completion.
- Combination Deadline: Note the February 2, 2028 deadline for consummating a business combination and the implications of the Nasdaq 36-Month Rule.
- Share Structure: Verify the outstanding share count: 20,125,000 Class A shares (subject to redemption) and 6,708,333 Class B Founder Shares.
- Warrant Terms: Review the exercise price of $11.50 per share and the redemption trigger price of $18.00 per share for public warrants.